vs

Side-by-side financial comparison of KRONOS WORLDWIDE INC (KRO) and Natera, Inc. (NTRA). Click either name above to swap in a different company.

Natera, Inc. is the larger business by last-quarter revenue ($665.5M vs $418.3M, roughly 1.6× KRONOS WORLDWIDE INC). Natera, Inc. runs the higher net margin — 7.1% vs -19.8%, a 26.9% gap on every dollar of revenue. On growth, Natera, Inc. posted the faster year-over-year revenue change (39.8% vs -1.1%). KRONOS WORLDWIDE INC produced more free cash flow last quarter ($81.9M vs $37.8M). Over the past eight quarters, Natera, Inc.'s revenue compounded faster (34.5% CAGR vs -6.5%).

Kronos Incorporated was an American multinational workforce management and human capital management cloud provider headquartered in Lowell, Massachusetts, United States, which employed more than 6,000 people worldwide.

Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA (cfDNA) testing technology, with a focus on women’s health, cancer, and organ health. Natera’s proprietary technology combines novel molecular biology techniques with a suite of bioinformatics software that allows detection down to a single molecule in a tube of blood. Natera operates CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendment...

KRO vs NTRA — Head-to-Head

Bigger by revenue
NTRA
NTRA
1.6× larger
NTRA
$665.5M
$418.3M
KRO
Growing faster (revenue YoY)
NTRA
NTRA
+40.9% gap
NTRA
39.8%
-1.1%
KRO
Higher net margin
NTRA
NTRA
26.9% more per $
NTRA
7.1%
-19.8%
KRO
More free cash flow
KRO
KRO
$44.1M more FCF
KRO
$81.9M
$37.8M
NTRA
Faster 2-yr revenue CAGR
NTRA
NTRA
Annualised
NTRA
34.5%
-6.5%
KRO

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
KRO
KRO
NTRA
NTRA
Revenue
$418.3M
$665.5M
Net Profit
$-82.8M
$47.3M
Gross Margin
-0.9%
Operating Margin
-15.1%
-3.4%
Net Margin
-19.8%
7.1%
Revenue YoY
-1.1%
39.8%
Net Profit YoY
-527.3%
187.9%
EPS (diluted)
$-0.72
$0.36

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
KRO
KRO
NTRA
NTRA
Q4 25
$418.3M
$665.5M
Q3 25
$456.9M
$592.2M
Q2 25
$494.4M
$546.6M
Q1 25
$489.8M
$501.8M
Q4 24
$423.1M
$476.1M
Q3 24
$484.7M
$439.8M
Q2 24
$500.5M
$413.4M
Q1 24
$478.8M
$367.7M
Net Profit
KRO
KRO
NTRA
NTRA
Q4 25
$-82.8M
$47.3M
Q3 25
$-37.0M
$-87.5M
Q2 25
$-9.2M
$-100.9M
Q1 25
$18.1M
$-66.9M
Q4 24
$-13.2M
$-53.8M
Q3 24
$71.8M
$-31.6M
Q2 24
$19.5M
$-37.5M
Q1 24
$8.1M
$-67.6M
Gross Margin
KRO
KRO
NTRA
NTRA
Q4 25
-0.9%
Q3 25
10.3%
Q2 25
12.7%
Q1 25
21.8%
Q4 24
20.4%
Q3 24
20.9%
Q2 24
20.0%
Q1 24
14.9%
Operating Margin
KRO
KRO
NTRA
NTRA
Q4 25
-15.1%
-3.4%
Q3 25
-4.2%
-16.5%
Q2 25
1.5%
-20.2%
Q1 25
7.8%
-15.8%
Q4 24
6.8%
-13.6%
Q3 24
8.0%
-8.9%
Q2 24
7.2%
-10.6%
Q1 24
4.1%
-20.2%
Net Margin
KRO
KRO
NTRA
NTRA
Q4 25
-19.8%
7.1%
Q3 25
-8.1%
-14.8%
Q2 25
-1.9%
-18.5%
Q1 25
3.7%
-13.3%
Q4 24
-3.1%
-11.3%
Q3 24
14.8%
-7.2%
Q2 24
3.9%
-9.1%
Q1 24
1.7%
-18.4%
EPS (diluted)
KRO
KRO
NTRA
NTRA
Q4 25
$-0.72
$0.36
Q3 25
$-0.32
$-0.64
Q2 25
$-0.08
$-0.74
Q1 25
$0.16
$-0.50
Q4 24
$-0.11
$-0.41
Q3 24
$0.62
$-0.26
Q2 24
$0.17
$-0.30
Q1 24
$0.07
$-0.56

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
KRO
KRO
NTRA
NTRA
Cash + ST InvestmentsLiquidity on hand
$33.2M
Total DebtLower is stronger
$557.4M
Stockholders' EquityBook value
$751.1M
$1.7B
Total Assets
$1.8B
$2.4B
Debt / EquityLower = less leverage
0.74×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
KRO
KRO
NTRA
NTRA
Q4 25
$33.2M
Q3 25
$27.7M
$1.0M
Q2 25
$18.9M
$16.0M
Q1 25
$20.5M
$17.8M
Q4 24
$106.7M
$22.7M
Q3 24
$94.8M
$29.5M
Q2 24
$133.8M
$90.3M
Q1 24
$120.7M
$69.1M
Total Debt
KRO
KRO
NTRA
NTRA
Q4 25
$557.4M
Q3 25
$626.2M
Q2 25
$589.3M
Q1 25
$557.2M
Q4 24
$507.4M
Q3 24
$554.3M
Q2 24
$423.7M
Q1 24
$426.9M
Stockholders' Equity
KRO
KRO
NTRA
NTRA
Q4 25
$751.1M
$1.7B
Q3 25
$804.7M
$1.3B
Q2 25
$846.8M
$1.2B
Q1 25
$847.0M
$1.2B
Q4 24
$817.0M
$1.2B
Q3 24
$847.4M
$878.5M
Q2 24
$774.6M
$836.5M
Q1 24
$774.4M
$794.1M
Total Assets
KRO
KRO
NTRA
NTRA
Q4 25
$1.8B
$2.4B
Q3 25
$1.9B
$1.8B
Q2 25
$1.9B
$1.8B
Q1 25
$1.9B
$1.7B
Q4 24
$1.9B
$1.7B
Q3 24
$1.9B
$1.6B
Q2 24
$1.7B
$1.5B
Q1 24
$1.7B
$1.5B
Debt / Equity
KRO
KRO
NTRA
NTRA
Q4 25
0.74×
Q3 25
0.78×
Q2 25
0.70×
Q1 25
0.66×
Q4 24
0.62×
Q3 24
0.65×
Q2 24
0.55×
Q1 24
0.55×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
KRO
KRO
NTRA
NTRA
Operating Cash FlowLast quarter
$92.1M
$73.9M
Free Cash FlowOCF − Capex
$81.9M
$37.8M
FCF MarginFCF / Revenue
19.6%
5.7%
Capex IntensityCapex / Revenue
2.4%
5.4%
Cash ConversionOCF / Net Profit
1.56×
TTM Free Cash FlowTrailing 4 quarters
$-40.4M
$109.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
KRO
KRO
NTRA
NTRA
Q4 25
$92.1M
$73.9M
Q3 25
$-7.9M
$59.4M
Q2 25
$20.7M
$37.6M
Q1 25
$-102.4M
$44.5M
Q4 24
$49.3M
$52.9M
Q3 24
$28.3M
$51.8M
Q2 24
$38.2M
$4.0M
Q1 24
$-43.3M
$27.0M
Free Cash Flow
KRO
KRO
NTRA
NTRA
Q4 25
$81.9M
$37.8M
Q3 25
$-17.4M
$37.0M
Q2 25
$9.5M
$11.7M
Q1 25
$-114.4M
$22.6M
Q4 24
$37.0M
$34.8M
Q3 24
$19.2M
$35.5M
Q2 24
$34.8M
$-7.7M
Q1 24
$-48.0M
$6.7M
FCF Margin
KRO
KRO
NTRA
NTRA
Q4 25
19.6%
5.7%
Q3 25
-3.8%
6.2%
Q2 25
1.9%
2.1%
Q1 25
-23.4%
4.5%
Q4 24
8.7%
7.3%
Q3 24
4.0%
8.1%
Q2 24
7.0%
-1.9%
Q1 24
-10.0%
1.8%
Capex Intensity
KRO
KRO
NTRA
NTRA
Q4 25
2.4%
5.4%
Q3 25
2.1%
3.8%
Q2 25
2.3%
4.7%
Q1 25
2.4%
4.3%
Q4 24
2.9%
3.8%
Q3 24
1.9%
3.7%
Q2 24
0.7%
2.8%
Q1 24
1.0%
5.5%
Cash Conversion
KRO
KRO
NTRA
NTRA
Q4 25
1.56×
Q3 25
Q2 25
Q1 25
-5.66×
Q4 24
Q3 24
0.39×
Q2 24
1.96×
Q1 24
-5.35×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons